ROIV Roivant Sciences Ltd.

NASDAQ
$35.50

Roivant Sciences Ltd. (ROIV) is expected to report earnings on November 16, 2026, before the market open. The consensus earnings estimate is a loss of $0.52 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +7.2% since its last earnings release on August 6, 2026.

Roivant Sciences Reported In-line with Estimates
Thursday, August 6, 2026 · 7:00 AM ET
Earnings Date
2nd Quarter, Sep 2026
Nov 16
Monday · 7:00 AM ET
Earnings Whisper
-
vs ($0.52)
Rev est $2.6M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $37.44

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Roivant Sciences Ltd.

Roivant's mission is to improve the delivery of healthcare to patients by treating every inefficiency as an opportunity.

Sector

Healthcare

Industry

Biotechnology

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.